What Dépist&vous does

Dépist&vous is a French digital health company, founded in October 2020 and headquartered in Bordeaux, that operates a web-based platform for cancer prevention and early screening. The core product is a digital prevention platform offering four personalized screening pathways (colorectal, skin, breast, and cervical cancer) built on medical questionnaires aligned with Haute Autorité de Santé recommendations, plus five prevention pathways covering self-palpation and self-monitoring for breast, testicular, prostate, and skin health. The platform generates personalized risk profiles, sends automated email and SMS reminders, and routes at-risk users to integrated teleconsultation via a partnership with Medaviz. It is hosted on HDS-certified French servers, is GDPR-compliant, and is one of the first applications referenced on Mon Espace Santé, the national health platform operated by Assurance Maladie.

The company monetizes through three primary revenue streams. Individual consumers pay €15 per year for a self-serve subscription via app.depistetvous.fr. Enterprises contract annual licenses to deploy the platform to employees as part of QVCT and RSE initiatives, with pricing quote-based and not publicly disclosed. Mutual insurance companies integrate the platform into their member portals as a value-added prevention service — Mutualia Grand Ouest's deployment alone covers 97,000+ members. In addition to the platform, Dépist&vous generates professional services revenue through Prevention@Work interactive workshops (1-hour sessions on cancer prevention themes) and on-site skin cancer screening days using dermatoscopic examination with tele-expertise review by dermatologists, with results delivered within 72 hours; 25 screening days were planned for 2025.

The company targets three customer segments — enterprises (large companies pursuing QVCT/RSE strategies), mutual insurance companies (adding prevention services to member offerings), and individuals aged 18-75 — and operates exclusively in France. Named enterprise and mutuelle customers span insurance (Allianz, MBA Mutuelle, Mutualia, Groupe Pasteur Mutualité), pharma (CSL Vifor, Servier, Takeda), medtech/healthcare (Philips, GE Healthcare), IT services (CGI), banking (Banque Populaire), and retail/consumer (Back Market, Partnaire, Zentiva). The company has a small team of approximately five employees plus identified leadership, is privately held by founder Dr. Charlotte Berthaut with no disclosed institutional funding, and has built strategic partnerships with ANDRH (HR professionals association, 6,250+ members), multiple patient associations (Keep A Breast, Movember, CerHom, Patients en Réseau, France Asso Cancer & Peau), and sponsors Bpifrance, Fondation Ramsay Générale de Santé, and Caisse des Dépôts.

Name

Dépist&vous

Legal name

Dépist&vous

Website

https://depistetvous.fr

Company type

Private

Founded year

2020

Operating status

Operating

Short description

Dépist&vous is a French digital health company operating a web-based cancer prevention and screening platform, serving enterprises, mutual insurance companies, and individual consumers across France.

Ownership category

akta.pro rank

Product category

Digital Health Platform

NAICS

Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Health Services (8000), Services-Medical Laboratories (8071)

akta.pro primary industry

Population Health Outreach, Preventive Care & Screening Virtual Programs (Payer-Sponsored) (HLALACAL)

akta.pro secondary industry

Care Navigation, Advocacy & Benefits Guidance Platforms (HLALADAJ)

Keywords

• Cancer screening platform
• Preventive health software
• Occupational health services
• Digital health screening
• Health risk assessment

Headquarters

HQ city

Bordeaux

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Individual Subscription: Annual subscription for individual consumers at €15 TTC/year, providing unlimited access to all platform services including screening questionnaires, prevention pathways, reminders, practitioner directory, and teleconsultation
2. Enterprise B2B Subscription: Annual enterprise licenses for companies deploying the platform to employees as part of RH/QVCT strategy. Includes platform access, workshops, and impact reporting
3. Mutual/Health Insurance Partnership: Integration partnerships with mutual insurance companies to embed the platform in their subscriber portals, providing prevention services as a value-added offering
4. Prevention@Work Workshops: 1-hour interactive workshops on health prevention topics (cancer prevention, skin cancer, breast cancer, men's cancers, cervical cancer, colorectal cancer, environmental health, nutrition, addictions), delivered digitally or on-site
5. On-Site Screening Days: Skin cancer screening days where nurses conduct dermoscopic examinations at client premises, with tele-expertise review by dermatologists and confidential results delivered within 72 hours

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Core offering

Dépist&vous operates a digital health platform that helps individuals assess their personal cancer risk and follow personalized screening pathways for breast, colorectal, cervical, prostate and skin cancers. The platform is complemented by two service lines for organizations: 'Ateliers Prévention@Work' workplace prevention workshops and on-site 'Journées de dépistage' screening days delivered at client sites.

Product overview

Dépist&vous is a digital health company offering a unified platform plus modular add-on services for cancer prevention and early screening. The core product is the Plateforme de prévention Dépist&vous — a web-based application providing four personalized cancer screening pathways (colorectal, skin, breast, and cervical cancer) through medical questionnaires, risk profiling, automated reminders, and educational content. This platform is complemented by two service modules: Ateliers Prévention@Work (interactive 1-hour workshops co-led by healthcare professionals and patient advocates, available digitally or on-site) and Journées de dépistage sur site (on-site skin cancer screening days with tele-expertise). The company targets enterprises, mutual insurance providers, and individual consumers in France.

Differentiator

Problem solved

Functional benefit

Brands

• Prévention@Work: Interactive 1-hour prevention workshops for enterprises covering cancer prevention topics including cancer prevention, skin cancer, breast cancer (Octobre Rose), male cancers (Movember), cervical cancer (Juin Vert), colorectal cancer (Mars Bleu), environmental health, nutrition, and addictions.

Products and services

• Plateforme de prévention Dépist&vous Web and mobile-accessible digital health platform that assesses individual cancer risk and provides personalized screening pathways for breast, colorectal, cervical, prostate and skin cancers, including guided e-learning content and integration with teleconsultation and Mon Espace Santé. Offered via €15/year individual subscription and quote-based enterprise licensing.
• Ateliers Prévention@Work Workplace prevention workshops delivered on-site for enterprise and mutuelle clients, designed to educate employees on cancer risk factors and screening. Sold to B2B customers as part of broader workplace prevention programs.
• Journées de dépistage sur site On-site screening days organized at the client's premises where healthcare professionals deliver cancer screenings to employees/insureds as part of a turnkey B2B prevention offering.

Quantifiable outcome

• 57% of platform users scheduled a doctor appointment after completing their screening pathway
• +5 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature6 records

Partnerships

Twelve partnerships are on record, tiered core, secondary and minor.

• ANDRH (Association Nationale des DRH)coreStrategic or Co-development Partner · 1 January 2025Strategic co-organization of the Challenge CAC (Companies Against Cancer) initiative. ANDRH is France's leading HR professionals association with 6,250+ members. The partnership leverages ANDRH's network to promote corporate cancer prevention among French enterprises and positions Dépist&vous as the go-to solution for HR decision-makers.
• MedavizcoreTechnology or IntegrationTeleconsultation integration partner enabling users identified as at-risk to immediately book teleconsultations with healthcare professionals directly through the platform.
• Philips FrancecoreStrategic or Co-development PartnerStrategic partnership with Philips, a global leader in health technology, to strengthen Philips' QVCT approach. Philips provides access to its employees while Dépist&vous delivers cancer prevention platform and workshops.
• Keep A BreastsecondaryStrategic or Co-development PartnerPatient association partner contributing to Prevention@Work workshops with patient perspectives on breast cancer awareness and prevention.
• MovembersecondaryStrategic or Co-development PartnerMen's health foundation partner contributing to workshops and awareness campaigns around prostate and testicular cancer prevention.
• CerHomsecondaryStrategic or Co-development PartnerPatient association for male cancer survivors contributing to men's health workshops and awareness initiatives.
• Patients en RéseausecondaryStrategic or Co-development PartnerCancer patient network contributing patient expertise to platform development and workshop facilitation, including Mon Réseau Cancer Colorectal.
• France Asso Cancer & PeausecondaryStrategic or Co-development PartnerSkin cancer patient association contributing to skin cancer prevention workshops and awareness campaigns.
• Assurance Maladie (Mon Espace Santé)coreStrategic or Co-development PartnerDépist&vous is one of the first applications referenced on Mon Espace Santé, the official national health platform. This government endorsement validates the platform's security, confidentiality, and ethics standards.
• BpifranceminorOthersSponsor of Challenge CAC initiative, contributing to the visibility and reach of the corporate cancer prevention challenge.
• Fondation Ramsay Générale de SantéminorOthersSponsor of Challenge CAC initiative, supporting corporate health prevention efforts.
• Caisse des DépôtsminorOthersSponsor of Challenge CAC initiative, contributing to the financing and support of corporate health prevention programs.

Scale indicators18 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Resilience: French digital health platform dedicated to supporting people affected by cancer, including prevention and care pathways. Most direct comparable given overlapping cancer-specific focus, French market, and B2B2C distribution through insurers and employers.
• Concilio: French B2B platform offering telehealth, medical second opinions, and corporate wellness services to enterprises and insurers. Closely aligned with Dépist&vous's enterprise HR/QVCT and mutuelle distribution model.

Broad incumbents

• Doctolib: Dominant French telehealth and appointment-booking platform serving both consumers and enterprises. Broad incumbent offering general virtual care infrastructure that could absorb cancer prevention workflows, competing for the same HR/QVCT budgets.
• Livi (Kry): European telehealth operator providing teleconsultations across multiple EU markets including France. Comparable as a payer- and employer-sponsored virtual care channel with consumer subscription and B2B distribution.
• Qare (by Vivendi/Livi): French telehealth service offering remote consultations and corporate health solutions. Comparable virtual-care offering sold to enterprises and insurers with similar prevention-adjacent positioning.
• Alan: French health insurance and prevention-focused insurer offering digital wellness and prevention tools to employers and members. Competes for the same HR/QVCT and mutuelle budgets with bundled insurance + prevention value proposition.
• MesDocteurs (by Teladoc/Livi): French telehealth platform providing remote consultations and health services. Comparable payer- and employer-sponsored virtual care positioning with prevention components.

Emerging players

• Satelia: French digital health platform supporting care pathways including prevention and follow-up; serves providers and payers. Emerging player with adjacent chronic-condition and prevention positioning similar to Dépist&vous's screening pathways.
• Bioserenity: French connected health company developing wearable diagnostic and telemedicine solutions. Comparable emerging player at intersection of digital health, diagnostics, and tele-expertise workflows.

Regional players

• H4D: French telemedicine booth manufacturer and operator enabling remote consultations in workplaces and underserved areas. Comparable enterprise-channel distribution model targeting prevention and primary care access.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInfr.linkedin.com/company/depistetvous
• Instagraminstagram.com/depistetvous

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dépist&vous